Stocks360

NanoString Technologies, Inc. (NSTG)

Stock analysis · NASDAQ · Healthcare · Medical - Instruments & Supplies

Share: Facebook X WhatsApp SMS
$0.11

Get deeper signals and personalized alerts

Free account signup in under 60 seconds

Create free account → I already have an account
Market Cap
$5.07M
PE (TTM)
-0.03
EPS (TTM)
N/A
Dividend Yield
0.00%
Beta
1.24
Day Range
$0.10 – $0.14
52-wk Range
$0.10 – $0.14
Avg Volume
N/A
Volume
21.43M

NanoString Technologies, Inc. (NSTG) is a publicly traded company in the Healthcare sector. Latest price: $0.11. Market cap $5.07M. Trailing PE -0.03. Sign in to Stocks360 for full DCF valuation, fundamentals, technicals, and AI-driven analysis.

Get full analysis → Short-Term Analysis →

Earnings

Most Recent
Feb 27, 2024
EPS $-0.95 vs est. $-0.76
Missed by $0.19

Proprietary Signals

Signal snapshot temporarily unavailable.

About NanoString Technologies, Inc.

NanoString Technologies, Inc. is a global innovator in scientific instrumentation, designing and producing advanced research tools for genomics and proteomics across the Americas, Europe, the Middle East, and Asia Pacific. Its flagship offering is the nCounter Analysis System, an automated platform renowned for its versatile digital detection and counting capabilities. This system includes both nCounter MAX and FLEX configurations, which integrate a Prep Station for automated liquid handling and sample preparation, alongside a Digital Analyzer. The Analyzer captures data by imaging fluorescent reporters within sample cartridges, then processes this information into usable output files. The company also offers the nCounter SPRINT Profiler, a compact instrument that streamlines liquid handling and digital analysis using a specialized microfluidic cartridge. Complementing its hardware, NanoString provides nSolver Analysis Software, a powerful program enabling researchers to verify, normalize, and interpret their experimental data. Further extending its product portfolio, NanoString supplies customizable CodeSets and pre-designed panels tailored for applications in oncology, immunolog…

Valuation

Trailing twelve months. Multiples relative to current market price.
P/E (TTM)-0.03×
P/S (TTM)0.04×
P/B0.11×
PEG0.00×
P/FCF (TTM)-0.03×
EV / EBITDA-1.00×
EV / Sales1.13×
Earnings Yield-3264.94%
Free Cash Flow Yield-2993.41%

Fundamentals

Trailing twelve months. Source: financial statements via market data.
Enterprise Value$143.32M
Revenue (TTM)$127.26M
Net Income (TTM)-$165.43M
Free Cash Flow (TTM)-$135.42M
Net Debt$138.25M
Working Capital$227.91M
Gross Margin48.55%
Operating Margin-119.58%
Net Margin-125.37%
Return on Equity-143.23%
Return on Invested Capital-50.72%

Peers

Recent News

  • No recent news available.

Related

Browse more tickers: sitemap